Joyce A Cramer1, Gus A Baker, Ann Jacoby. 1. Department of Psychiatry, Yale University School of Medicine, 950 Campbell Avenue (G7E), New Haven, CT 06516-2770, USA. joyce.cramer@yale.edu
Abstract
PURPOSE: This report describes the initial steps for development of a new scale to assess seizure severity as a treatment response. METHODS: Standard methodology was used to develop the test instrument. Item generation was performed by selecting items from other questionnaires, and asking patients and epileptologists about seizure components. Face and content validity were assessed in a pilot study with patients and observers. The questionnaire was formatted as a structured interview for a reliability study. Construct validity was assessed with three existing questionnaires. Inter-rater reliability and test-retest reliability were performed as two independent ratings on one day, and one re-interview. RESULTS: Based on item generation and pilot testing (33 patients, 28 observers), the Seizure Severity Questionnaire (SSQ) was organized into warning, activity-movement, and recovery (cognitive, emotional, and physical aspects) stages of seizures. Questions reviewed duration, severity, bothersomeness and overall ratings, and the most bothersome aspect of seizures. The mean SSQ Summary Score was 5.78+/-3.24, inter-rater reliability was 0.76 (N=91), and test-retest reliability was 0.74 (N=63). Construct validity showed statistically significant correlations with other scales. CONCLUSION: This study has explored the psychometric properties of the SSQ for face and content validity, inter-rater and test-retest reliability, and construct validity. The Summary Score reliably represents the major components of seizures.
PURPOSE: This report describes the initial steps for development of a new scale to assess seizure severity as a treatment response. METHODS: Standard methodology was used to develop the test instrument. Item generation was performed by selecting items from other questionnaires, and asking patients and epileptologists about seizure components. Face and content validity were assessed in a pilot study with patients and observers. The questionnaire was formatted as a structured interview for a reliability study. Construct validity was assessed with three existing questionnaires. Inter-rater reliability and test-retest reliability were performed as two independent ratings on one day, and one re-interview. RESULTS: Based on item generation and pilot testing (33 patients, 28 observers), the Seizure Severity Questionnaire (SSQ) was organized into warning, activity-movement, and recovery (cognitive, emotional, and physical aspects) stages of seizures. Questions reviewed duration, severity, bothersomeness and overall ratings, and the most bothersome aspect of seizures. The mean SSQ Summary Score was 5.78+/-3.24, inter-rater reliability was 0.76 (N=91), and test-retest reliability was 0.74 (N=63). Construct validity showed statistically significant correlations with other scales. CONCLUSION: This study has explored the psychometric properties of the SSQ for face and content validity, inter-rater and test-retest reliability, and construct validity. The Summary Score reliably represents the major components of seizures.
Authors: Han Yan; Lauren Siegel; Sara Breitbart; Carolina Gorodetsky; Hernan D Gonorazky; Ivanna Yau; Cristina Go; Elizabeth Donner; Suneil K Kalia; Alfonso Fasano; Alexander G Weil; Aria Fallah; George M Ibrahim Journal: Childs Nerv Syst Date: 2020-09-15 Impact factor: 1.475
Authors: Laura H Goldstein; Emily J Robinson; Izabela Pilecka; Iain Perdue; Iris Mosweu; Julie Read; Harriet Jordan; Matthew Wilkinson; Gregg Rawlings; Sarah J Feehan; Hannah Callaghan; Elana Day; James Purnell; Maria Baldellou Lopez; Alice Brockington; Christine Burness; Norman A Poole; Carole Eastwood; Michele Moore; John Dc Mellers; Jon Stone; Alan Carson; Nick Medford; Markus Reuber; Paul McCrone; Joanna Murray; Mark P Richardson; Sabine Landau; Trudie Chalder Journal: Health Technol Assess Date: 2021-06 Impact factor: 4.014
Authors: Laura H Goldstein; John D C Mellers; Sabine Landau; Jon Stone; Alan Carson; Nick Medford; Markus Reuber; Mark Richardson; Paul McCrone; Joanna Murray; Trudie Chalder Journal: BMC Neurol Date: 2015-06-27 Impact factor: 2.474
Authors: Lauren Siegel; Han Yan; Nebras Warsi; Simeon Wong; Hrishikesh Suresh; Alexander G Weil; John Ragheb; Shelly Wang; Curtis Rozzelle; Gregory W Albert; Jeffrey Raskin; Taylor Abel; Jason Hauptman; Dewi V Schrader; Robert Bollo; Matthew D Smyth; Sean M Lew; Melissa Lopresti; Dominic J Kizek; Howard L Weiner; Aria Fallah; Elysa Widjaja; George M Ibrahim Journal: BMJ Open Date: 2022-04-08 Impact factor: 2.692
Authors: Robert S Fisher; Pegah Afra; Micheal Macken; Daniela N Minecan; Anto Bagić; Selim R Benbadis; Sandra L Helmers; Saurabh R Sinha; Jeremy Slater; David Treiman; Jason Begnaud; Pradheep Raman; Bita Najimipour Journal: Neuromodulation Date: 2015-12-13
Authors: Laura H Goldstein; Emily J Robinson; John D C Mellers; Jon Stone; Alan Carson; Trudie Chalder; Markus Reuber; Carole Eastwood; Sabine Landau; Paul McCrone; Michele Moore; Iris Mosweu; Joanna Murray; Iain Perdue; Izabela Pilecka; Mark P Richardson; Nick Medford Journal: Psychol Med Date: 2020-05-11 Impact factor: 7.723